IFNG and neoplasm: Prior studies have shown that the EGFR ligand EGF dampens the interferon-γ (IFN-γ)-mediated induction of major histocompatibility complex (MHC) class II molecules, which is essential in adaptive immune responses, including anti-tumor immune responses [5].